Indivior PLC Schedule 13G passive stakes

Madison Avenue International LP and affiliated entities report beneficial ownership of 4,315,162 shares, representing 3.5% of Indivior Pharmaceuticals' common stock as of March 31, 2026.

Fuller & Thaler Asset Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4,529,583.47 shares of Indivior Pharmaceuticals, Inc. common stock, representing 3.72% of the class.

Vanguard Portfolio Management has reported beneficial ownership of 6.55% of Indivior Pharmaceuticals Inc.'s common stock as of March 31, 2026.

Vanguard Capital Management has filed a Schedule 13G reporting a 5.35% beneficial ownership stake in Indivior Pharmaceuticals Inc.

Millennium Management LLC and affiliates reported their beneficial ownership in Indivior Pharmaceuticals, Inc. common stock has fallen to 3.8%, ceasing to be a 5% beneficial owner.

Fuller & Thaler Asset Management, Inc. has reported a passive 5.10% ownership stake in Indivior Pharmaceuticals, Inc. as of December 31, 2025.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a 2.9% beneficial ownership stake in Indivior Pharmaceuticals, Inc. as of December 31, 2025.

BlackRock, Inc. has reported an increased beneficial ownership of 14.3% in Indivior PLC's common stock, holding 17,806,183 shares.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have reported a decrease in their beneficial ownership of Indivior PLC ordinary shares to 2.0%.

Deerfield Management and its affiliates have reported a reduction in their beneficial ownership of Indivior PLC ordinary shares to 3.70%, falling below the 5% threshold.

The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, reported a 5.2% beneficial ownership stake in Indivior PLC as of September 30, 2025.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a 7.8% beneficial ownership stake in Indivior PLC.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.8% of Indivior PLC's common stock as of June 30, 2025.

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have filed an amended Schedule 13G, confirming their collective beneficial ownership of 8.47% of Indivior PLC's Ordinary Shares.

Morgan Stanley and its subsidiary, Morgan Stanley & Co. International plc, have filed an amended Schedule 13G indicating they are no longer beneficial owners of more than five percent of Indivior PLC's Ordinary Shares.

A group of investment entities led by Eli Samaha, collectively known as the Madison Avenue Group, has disclosed a 6% beneficial ownership stake in Indivior PLC, holding 7,438,153 ordinary shares.

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have collectively reported a continued 7.16% beneficial ownership in Indivior PLC as of December 31, 2024, held for passive investment purposes.

The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 6.5% in Indivior PLC's ordinary shares as of December 31, 2024.